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The aim of this study is to explore a bridge connecting the mechanism basis and macro syndromes of coronary heart disease with
experimental animal models. GC-MS technique was used to detect the metabolites of plasma samples in mini swine models with
myocardial infarction (MI) and patients with unstable angina (UA). 30 metabolites were detected in the plasma samples of more
than 50 percent of model group and control group in swine, while 37 metabolites were found in the plasma samples of UA patients
and healthy control group. 21 metabolites in the plasma samples of swine model and 20 metabolites in patients with UA were
found of signiﬁcant value. Among which, 8 shared metabolites were found of low level expression in both swine model and UA
patients. Independent Student’s t-test, principal component analysis (PCA), and hierarchicalcluster analysis (HCA) were orderly
applied to comprehend inner rules of variables in the data. The 8 shared metabolites could take place of the 21 or 20 metabolites
in classiﬁcation of swine model with MI and UA patients, which could be considered as a bridge connecting the mechanism basis
and macrosyndromes of swine model with MI and UA patients.
1.Introduction
Coronary heart disease (CHD) causes more than one million
C h i n e s et od e a t he a c hy e a r[ 1]. Unstable angina (UA) is one
ofthemostdangeroustypesofCHDthathasahighmortality
and morbidity in the world. Comparing the metabolites in
swine model and patients with UA of blood stasis syndrome
at the level of metabolomics to explore the underlying
mechanism is a new way deserved trying.
Metabonomics, the study of metabolites and their roles
in various disease states, is a novel methodology arising from
the postgenomics era. In the last decade, “metabonomics”
has demonstrated enormous potential in further under-
standing of many diseases, including work in cardiovascu-
lar research [2]. Metabonomics is now recognized as an
independently and widely used technique for deriving new
biochemical-based assays for disease diagnosis, understand-
ing the relationships between gene function and metabolic
control in health and disease, and identifying combination
biomarkers for disease [3].
GC (gas chromatography) plays an important role in
metabonomics research nowadays. Chromatography has
been used mainly in bioﬂuid analysis, especially for target
component analysis but not for whole sample proﬁling
combined with chemometrics [4]. The high separation
power and the ability to achieve high sensitivity are strong
incentives for the consideration of its use in bioﬂuid
ﬁngerprinting as well. So chromatography would provide
additional and complementary information that cannot be
achieved with NMR [5].
Inthisstudy,bloodsamplesofUApatientswerecollected
under clinical epidemiology and chemically detected by
metabolomics methods. Meanwhile, blood samples of swine
model with MI were detected by metabolomics methods.
As we had found in former research, feature selection-
based data mining methods is more suitable for identifying
biomarkers for UA [6]. Alternatively, we combined indepen-
dent t-test and classiﬁcation-based data mining methods.
The novel method presented here provides a better insight
into the pathology of a disease.2 Evidence-Based Complementary and Alternative Medicine
2.MaterialsandMethods
2.1. Animal Sample Preparation. Seventeen male miniswine
weighed 25 ± 5kg were randomly divided into two groups.
The model group was composed of nine swine, while the
control group was eight. The swine in model group (n = 9)
was placed with Ameroid constrictor (Research Instrument
SW, USA) at the left anterior descending coronary artery to
gradually induce chronic myocardial infarction (MI). The
swine in control group (n = 8) was chest-opened and
coronary artery-isolated without placing any constrictor.
Based on early results of dynamic observations, evaluations
were performed four weeks after operation. Meanwhile,
blood was obtained from former cava vena.
2.2. Evaluation of Swine Model with MI and Blood Stasis
Syndrome. Evaluation of swine with MI and blood stasis
syndrome was performed from ﬁve parts. Basic phenotype
changes,ECG,echocardiography,coronaryangiography,and
hemorrheology were used to assess the animal model.
ECG. More than 0.1mV ST segment depression and inver-
sion T waves were observed in several leads of surface
electrocardiogram of model animals. But no signiﬁcant
arrhythmia was found in experimental period.
Echocardiography. Thestructureandfunctionofleftventric-
ular were evaluated by echocardiography. Compared with
sham-operated animals, there was great increase of end-
systolic volume (P<0.05), end-diastolic volume (P<0.05),
end-systolic diameter (P<0.01), and end-diastolic diameter
(P<0.01) in model animals. Anterior wall thickness of
both papillary muscle and apex level was decreased at end-
diastolic and end-systolic in model animals (P<0.05, P<
0.01). Meanwhile, the apex of the left ventricular anterior
systolic wall thickening decreased (P<0.01). In addition,
septal thickness at the end-systolic decreased (P<0.05).
All the results above showed a segmental dysfunction of
the left ventricular. There were no signiﬁcant changes in
stroke volume, ejection faction, fraction of shortening, and
E/A, which suggested that cardiac function was still in
compensatory period.
Coronary Angiography. Ex vivo angiography performed
more than 90% occlusion or even completely block of the
left anterior descending artery by the Ameroid constrictor in
model animals. TIMI ﬂow grade I or II was observed in most
model animals. There was good ﬁlling in the left anterior
descendingarterywithTIMIﬂowgradeIIIinsham-operated
animals.
Phenotype Information. Model animals appeared mental
stress, irritation, fear, violent behaviors, strong self-defense,
pilose disorderly, and lack of luster, while sham-operated
animals’ performances gradually returned to normal, with
increased appetite, neat, and shiny pilose.
Hemorrheology. Comparedwithsham-operatedanimals,the
blood viscosity of model animals increased signiﬁcantly at a
shear rate of high (P<0.05), mid (P<0.01), low (P<0.01).
It was found that swine in MI group had signiﬁcant
changes when compared with the sham operation group
fromeachaspect.Combinedtheﬁveaspectsabove,theswine
could be diagnosed as MI with blood stasis syndrome.
The results of echocardiography and hemorrheology
of mini swine were given in Supplemental Table 1. (see
Supplementary material available online at doi:10.1155/
2012/638723)
2.3. Clinical Blood Sample Collection. Patients who suﬀered
from UA and blood stasis at Dongzhimen Hospital aﬃliated
to Beijing University of Chinese Medicine were included
in the screening of metabolite biomarker cohort study. All
patients aged from 55 to 75 were eligible for enrollment.
Diagnosis standard of CHD refers to “Treatment Guide of
Stable Angina” (ACC/AHA/ACP-ASIM, 1999) and “Diagno-
sis and Treatment Recommendations of Unstable Angina”
(Chinese Society of Cardiology, 2000) [7, 8]. Diagnosis
standard of blood stasis syndrome refers to “Guiding prin-
ciples for the clinical study of Chinese Medicines” (2002)
and Standard of syndrome diﬀerentiation of coronary heart
disease (1990) [9, 10].
Patients were excluded from the case population in four
conditions:thosewhosuﬀeredfromacutemyocardialinfarc-
tion (AMI), infective cardiomyopathy, cardiac neurosis, or
intercostal neuralgia; those who suﬀered from angina that
was caused by polyarthritis rheumatica acuta, great pox,
inborn coronary abnormity, hypertrophic cardiomyopathy
or aortic valve stenosis; besides UA, those who also suﬀered
from stroke, diabetes mellitus, pulmonary infection, nephri-
tis, renal failure, urinary system infection, rheumatism, or
osteoarthrosis; women in pregnant or in lactation.
The control group included healthy people that of no
signiﬁcantlydiﬀerentbaselinecomparedwiththecasegroup.
After these analyses, blood samples from a total of 27 UA
patients with blood stasis syndrome and 15 healthy controls
were enrolled for the further metabolomic analysis. The local
ethics committee of Beijing University of Chinese Medicine
approved the study protocol, and all patients provided
written and informed consent.
The demographic details of included subjects were given
in Supplemental Table 2.
2.4. Gas Chromatography: Mass Spectrometry (GC-MS) Anal-
ysis of Human and Animal Plasma. Add 250µL acetonitrile
and centrifuged to 100µL plasma samples after ice-bathing
for 10 minutes. Place 250µL supernatant plasma extraction
liquid in derivation reaction bottle and blew by N2. Add
50µLmethoxylaminepyridine solutionwithaconcentration
of15mg/mLtouniformlymixed,whichwasinoximationfor
one hour and then added by 50µL derivation reagent (vol-
ume ratio of MSTFA:TMCS is 100:1) to uniformly mixed
foronehour.Add100µLskellysolveCcontaining0.1mg/mL
docosane to uniformly mixed and then centrifuged for 10
minutes.TheresultingclearsupernatantliquidwasextractedEvidence-Based Complementary and Alternative Medicine 3
to small volume sample injection vessel for GC-MS analysis,
whose conditions were given as following. Temperature of
sample injection was 270◦C, none-split stream sampling
was used, and quantity of injection was 1µL. Solvent was
delayed for 7 minutes. Temperature was initialed at 80◦Cf o r
5 minutes and then gradually raised to 300◦C with a speed
of 10◦C/min. It remained at 300◦C for 5 minutes. Interface
temperature was 280◦C, and ion source temperature was
230◦C. Ionizing voltage was 70eV; quadrupole temperature
was 150◦C. Helium was used as carrier gas with a ﬂow rate of
mL/min. 45∼550m/z frequency was used to completely scan
the samples.
2.5. Data Mining Methods. Independent Student’s t-test,
Principalcomponentanalysis(PCA),andhierarchicalcluster
analysis (HCA) were orderly applied to comprehend inner
rules of variables in the data. These methods linearly
investigated the data from one variable (t-test associated
method) to multiple variables (PCA and so on). Moreover,
the methods involved unsupervised methods (PCA and
HCA).Thesystematicalapplicationofthestatisticalmethods
guaranteed the useful information of the disease mined by
them.
3. Results
3.1. Detection of Signiﬁcantly Diﬀerent Metabolites by Stu-
dent’s t-Test Statistics. Student’s t-test was initially employed
to detect metabolites that are of signiﬁcant diﬀerence
between model and sham operation in swine as well as
between UA patients and healthy people. 21 metabolites in
the plasma samples of swine model, and 20 metabolites in
patients with UA were found of signiﬁcantly value. Among
which, 8 shared metabolites between swine model and UA
patients were lined in Table 1.T h ed i ﬀerent metabolites were
lined in Table 2. Supplemental Table 3 listed the identiﬁed
compounds and their retention time.
3.2. The Results of PCA Analysis. PCA results showed that 21
metabolitesclassiﬁedminiswinemodelfromshamoperation
group, 20 metabolites classiﬁed UA patients from healthy
people, moreover, the 8 shared metabolites between swine
model and UA patients can distinguish model group from
shamoperationgroupinswineandUApatientsfromhealthy
people as well. PCA results of miniswine with MI and blood
stasis syndrome were showed in Figure 1. PCA results of UA
patients with blood stasis syndrome and healthy people were
showed in Figure 2.
3.3. The Results of Hierarchical Cluster Analysis (HCA). It
showed that the 8 shared metabolites are of the same value
withthe21or20metabolitesinclassiﬁcationofmodelgroup
from sham operation group in swine and UA patients from
healthy people (Figures 3 and 4).
Table 1: The shared metabolites in swine model and UA patients.
Number Metabolite
P of
swine
model
Ascending
(↑)o r
descend-
ing
(↓)
P of UA
patients
Ascending
(↑)o r
descend-
ing
(↓)
1
1,4-
Benzenedica-
rboxylic acid
0 ↓ 0.019387 ↓
2
1,5-
Anhydrogluc-
itol
0.044 ↓ 0.005023 ↓
3
2-Keto-d-
gluconic
acid
0.003 ↓ 0.056989 ↓
4 Azelaic acid 0 ↓ 0.056989 ↓
5 Heptanedioic
acid 0 ↓ 0.031348 ↓
6 Pentanedioic
acid 0.019 ↓ 0.049076 ↓
7 Ribitol 0.03 ↓ 0.010673 ↓
8 Serine 0.001 ↓ 0.021365 ↓
Table 2: The diﬀerent metabolites in swine model and UA patients.
Animal model Clinical patients
Metabolite P Metabolite P
2-Keto-1-gluconic acid 0.002 Tetracosanoic acid 0.017749
4-Pyrimidinamine 0.011 11-Eicosanoic 0.012502
Aminomalonic acid 0 4(1H) Pyridinone 0.003801
Butanedioic acid 0.008 Docosanoic acid 0.023955
Butanoic acid 0.032 Glucopyranoside 0.005449
Decanoic acid 0.015 Myo-Inositol 0.010473
D-Fructose 0 Octadecanoic acid 6.22E-05
Glutamine 0.002 citrazinic acid 0.003344
L-Cysteine 0.032 D-gluconic acid 0.015724
L-threonine 0.001 Glucose oxime 0.005449
L-Valine 0 Hexadecanoic acid 0.00186
Thiazolidine-4-
carboxylic
acid
0.044 Tetracosanoic acid 0.017749
Urea 0.001
4. Discussion
Low level expressions of the eight molecules, 1,4-ben-
zenedicarboxylic acid, 1,5-anhydroglucitol, 2-keto-d-glu-
conicacid,azelaicacid,heptanedioic acid,pentanedioic acid,
ribitol, and serine were detected in swine models as well
as in UA patients, which could be considered as a bridge
connecting the mechanism basis and macrosyndromes of
swinemodelwithMIandUApatients.Butfurtherresearches
need to be carried out, and more evidence needs to be
investigated to conﬁrm this hypothesis. Plasma concentra-
tion of 1,5-anhydroglucitol decreased in diabetic patients has
been conﬁrmed [11, 12]. In order to eliminate interferences,4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: PCA scores’ plots of miniswine. (a) is classiﬁed by the 21 metabolites in the plasma samples of swine model, and (b) is classiﬁed
by the 8 same metabolites.
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Figure2:PCAscoresplotsofUApatients.(a)isclassiﬁedbythe20metabolitesintheplasmasamplesofpatientswithUA,and(b)isclassiﬁed
by the 8 same metabolites. Notes: X-axis represents the ﬁrst component of the metabolite data. Y-axis represents the second component,
and Z-axis represents the third component.
diabetes patients were excluded in our research. Our study
found that low expression of 1,5-anhydroglucitol existed in
UApatientswithbloodstasissyndromeaswellasinMIswine
with blood stasis syndrome. Besides 1,5-anhydroglucitol,
the other seven low expressed molecules are newly found.
We also found that sugar and fatty acids decreased in UA
patients [13]. It indicated that UA may correlate with energy
metabolic obstacle and inﬂammatory reaction. Low level
expression of the eight molecules observed in our study may
provide an important target for future study.
GC-MS is mainly used in plant metabonomics [14]. In
order to apply GC-MS analysis, samples need to undergo the
derivatization process to increase its stability and volatility.
Therefore, GC-MS analysis is limited to detect volatile
substances and cannot be used to analyze thermal instable
substances, such as lipid membrane, or metabolites of highEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Hierarchical cluster diagrams of miniswine. (a) is classiﬁed by the 21 metabolites in the plasma samples of swine model and
control, and (b) is classed by the 8 same metabolites. Notes: X-axis represents the sample numbers. The Y-axis represents the linkage
distance (0 = control group; 1 = model group).
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Figure 4: Hierarchical cluster diagrams of UA patients and healthy controls. (a) is classiﬁed by the 20 metabolites in the plasma samples
of UA patients and healthy controls, and (b) is classiﬁed by the 8 same metabolites. Notes: X-axis represents the sample numbers. Y-axis
represents the linkage distance (0 = healthy control group; 1 = UA patients group).
molecular weight. In this study, we used GC-MS to analyze
metabolites diﬀerence of plasma in swine model and in UA
patients. In future study, other metabonomics technology
can be used in corporately to examine more metabolites
and further explore the underlying mechanisms of UA.
Another interesting research is to investigate whether similar
metabolic changes also exist in other animal models of
coronary heart disease.
5. Conclusion
In this study, the plasma samples of UA patients and MI
swine model with blood stasis syndrome were used to select
biomarkers in the level of metabolomics. Student’s t-test
was initially employed to detect metabolites that are of
signiﬁcant diﬀerence between model and sham operation
group in swine as well as between UA patients and healthy
control group. 21 metabolites in the plasma samples of swine
model and 20 metabolites in patients with UA were found of
signiﬁcant value. Among which, 8 shared metabolites were
found of low level expression in both swine model and
UA patients. Then, independent student’s t-test, principal
component analysis (PCA), and hierarchical cluster analysis
(HCA) were orderly applied to comprehend inner rules of
variables in the data. The results indicated that the 8 shared
metabolites can take place of the 21 or 20 metabolites in
the classiﬁcation of swine model with MI and patients with
UA, which could be considered as a bridge connecting the
mechanism basis and macrosyndromes of swine model with6 Evidence-Based Complementary and Alternative Medicine
MI and UA patients. This research is for the ﬁrst time
trying to explore a bridge connecting the mechanism basis
and macrosyndromes of human disease with experimental
animal models by comparing the metabolites diﬀerences in
human and animal plasma samples. But further researches
need to be carried out, and more evidences need to be
investigated to conﬁrm this hypothesis.
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